Melanoma-Specific Antigens
-
Subject Areas on Research
- Cell adhesion protein expression in melanocytic matricoma.
- D6.1, a murine antimelanoma monoclonal antibody from congenitally athymic nude mice immunized with purified melanoma tumor-associated antigen.
- Expression of MAGE and GAGE in high-grade brain tumors: a potential target for specific immunotherapy and diagnostic markers.
- Fine-needle aspiration diagnosis of psammomatous melanotic schwannoma.
- Hepatic angiomyolipoma and hepatic stellate cells share a similar gene expression profile.
- Identification of a secreted Mr 95,000 glycoprotein in human melanocytes and melanomas by a melanocyte specific monoclonal antibody.
- Immune response of chimpanzee to purified melanoma 250 kilodalton tumor-associated antigen.
- Immune selection after antigen-specific immunotherapy of melanoma.
- Immunotherapy for malignant melanoma with a tumor cell vaccine.
- In vivo evaluation of cell mediated immunity against human melanoma.
- In vivo tumor localization using tumor-specific monkey xenoantibody, alloantibody, and murine monoclonal xenoantibody.
- MAGE-1-specific precursor cytotoxic T-lymphocytes present among tumor-infiltrating lymphocytes from a patient with breast cancer: characterization and antigen-specific activation.
- Multiple assay characterization of murine monoclonal antimelanoma antibodies.
- Pediatric conjunctival melanoma arising from a compound nevus.
- Proliferation indices correlate with diagnosis and metastasis in diagnostically challenging melanocytic tumors.
- Superantigen enhanced protection against a weak tumor-specific melanoma antigen: implications for prophylactic vaccination against cancer.
- The tumor biology of melanoma nodal metastases.
- Threshold levels of gene expression of the melanoma antigen gp100 correlate with tumor cell recognition by cytotoxic T lymphocytes.
- Unique proteins defined by monoclonal antibodies specific for human melanoma. Some potential clinical applications.